Compounds > n-methyl-3,4-methylenedioxyamphetamine
Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Cardiomyopathies

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Cardiomyopathies in 1 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koczor, CA1
Ludlow, I1
Hight, RS1
Jiao, Z1
Fields, E1
Ludaway, T1
Russ, R1
Torres, RA1
Lewis, W1

Other Studies

1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Cardiomyopathies

ArticleYear
Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.
    Toxicological sciences : an official journal of the Society of Toxicology, 2015, Volume: 148, Issue:1

    Topics: Animals; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotoxins; Circadian Rhythm Signaling Peptides a

2015